Dr. Franziska Richter, PhD, DVM, a former member of Marie-Françoise Chesselet‘s laboratory at UCLA, won an Abstract Prize at the Alpha-Synuclein: Gateway to Parkinsonism- Innsbruck Course for her presentation, entitled The molecular tweezer CLR01 reduces alpha-synuclein accumulation and improves motor deficits in a mouse model of Parkinson’s disease. The Prize was given by the Directors of the meeting and F1000. While at UCLA, Dr. Richter, who currently works at the Institute of Pharmacology, Pharmacy and Toxicology at the University of Leipzig , led the study of CLR01 in a mouse model of Parkinson’s disease and found improvement in motor deficits in correlation with reduction of brain pathology. The study gives hope that CLR01 can be developed as therapy for Parkinson’s disease and other synucleinopathies.


image 2

Dr. Richter (left) with Pam Bower, Secretary of the MSA Coalition (center) and Dr. Nadia Stefanova, University of Innsbruck (right).